ETFsXtrackers MSCI China UCITS ETF 1D
Xtrackers
Xtrackers MSCI China UCITS ETF 1D
XCS7 LSEDistributingLuxembourg
Last close · EUR
7.34EUR
-0.13% · -€0.01
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
XCS7Base
- Fund charges
- Not publishedFee basis unverified
- Fund size
- Not published
- Return 1Y
- -20.0%
- Sharpe 3Y
- 0.23
- Volatility 1Y
- 15.1%annualised
- Holdings
- 578Fund holdings
Performance
Compare
- XCS7-20.0%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| XCS7 | -4.9% | -8.9% | -10.1% | -14.0% | -20.0% | +20.0% | - |
| MSCI World | +0.4% | +4.9% | +10.8% | +16.3% | +15.9% | +75.5% | +71.2% |
| Gap to MSCI World | -5.3% | -13.8% | -20.9% | -30.3% | -35.9% | -55.6% | - |
Risk and return
Sharpe ratio · 3Y
0.23
Below MSCI World · 1.24- Return p.a.
- +5.7%
- Volatility
- 24.1%
- Max loss
- -22.2%Oct 2026
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
XCS7
0.23
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 42.4%
- Holdings
- 578
- As of
- 1TENCENT HOLDINGSKYG87572163413.27%
- 2ALIBABA GROUP HOLDINGKYG0171911429.18%
- 3CHINA CONSTRUCTION BANK CORP HCNE1000002H14.87%
- 4INDUSTRIAL AND COMMERCIAL BANK OFCNE1000003G12.90%
- 5XIAOMIKYG9830T10672.55%
- 6BANK OF CHINA LTD HCNE1000001Z52.32%
- 7MEITUANKYG5966910412.03%
- 8PDD HOLDINGS ADSUS72230410281.79%
- 9NETEASEKYG6427A10221.75%
- 10PING AN INSURANCE (GROUP) CO OF CHCNE1000003X61.72%
Countries
Classified 98.9%
China96.6%
- Largest
- 96.6%China
- Top 3
- 98.5%
- Effective number
- 1.11 / HHI
Market cap
Weight vs holdings
42.4%of the fund sits in the top 10 holdings
42.4%26.2%21.9%9.4%
WeightHoldings
40150378
- Holdings 1-10
- Holdings 11-50
- Holdings 51-200
- Holdings 201+
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.